BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 22345416)

  • 1. Malignant pleural mesothelioma.
    Chen SE; Pace MB
    Am J Health Syst Pharm; 2012 Mar; 69(5):377-85. PubMed ID: 22345416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview on ongoing or planned clinical trials in Europe.
    Favaretto A
    Lung Cancer; 2005 Jul; 49 Suppl 1():S117-21. PubMed ID: 15950791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.
    Pasello G; Nicotra S; Marulli G; Rea F; Bonanno L; Carli P; Magro C; Jirillo A; Favaretto A
    Lung Cancer; 2011 Sep; 73(3):351-5. PubMed ID: 21296448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant pleural mesothelioma.
    Kindler HL
    Curr Treat Options Oncol; 2000 Oct; 1(4):313-26. PubMed ID: 12057157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience.
    Flores RM
    Lung Cancer; 2005 Jul; 49 Suppl 1():S71-4. PubMed ID: 15950805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant pleural mesothelioma: current concepts in treatment.
    Tsiouris A; Walesby RK
    Nat Clin Pract Oncol; 2007 Jun; 4(6):344-52. PubMed ID: 17534390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.
    Thieke C; Nicolay NH; Sterzing F; Hoffmann H; Roeder F; Safi S; Debus J; Huber PE
    Radiat Oncol; 2015 Dec; 10():267. PubMed ID: 26715491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic treatments for mesothelioma: standard and novel.
    Kindler HL
    Curr Treat Options Oncol; 2008 Jun; 9(2-3):171-9. PubMed ID: 18770046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
    Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality therapy in mesothelioma: role of chemotherapy.
    Vogelzang NJ
    Thorac Surg Clin; 2004 Nov; 14(4):531-42. PubMed ID: 15559060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.
    Elkiran ET; Kaplan MA; Sevinc A; Aksoy S; Demirci U; Seker M; Harputluoglu H; Ozdemir NY; Isik F; Ulas A; Inanc M; Arslan UY; Dogu GG; Isikdogan A; Buyukberber S;
    Med Oncol; 2012 Dec; 29(5):3147-54. PubMed ID: 22722923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates in the diagnosis and treatment of malignant pleural mesothelioma.
    Katzman D; Sterman DH
    Curr Opin Pulm Med; 2018 Jul; 24(4):319-326. PubMed ID: 29553973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapies in malignant pleural mesothelioma: a review of clinical studies.
    Greillier L; Marco S; Barlesi F
    Anticancer Drugs; 2011 Mar; 22(3):199-205. PubMed ID: 21263312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemetrexed: a multitargeted antifolate.
    Rollins KD; Lindley C
    Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management options for malignant pleural mesothelioma: clinical and cost considerations.
    Goudar RK
    Drugs; 2007; 67(8):1149-65. PubMed ID: 17521217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
    Iwahori K; Serada S; Fujimoto M; Ripley B; Nomura S; Mizuguchi H; Shimada K; Takahashi T; Kawase I; Kishimoto T; Naka T
    Int J Cancer; 2013 Jan; 132(2):459-71. PubMed ID: 22532243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant mesothelioma 2008.
    Zervos MD; Bizekis C; Pass HI
    Curr Opin Pulm Med; 2008 Jul; 14(4):303-9. PubMed ID: 18520263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary treatment of malignant pleural mesothelioma.
    Ceresoli GL; Gridelli C; Santoro A
    Oncologist; 2007 Jul; 12(7):850-63. PubMed ID: 17673616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts in malignant pleural mesothelioma.
    Kaufman AJ; Pass HI
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.